(ORA) Ormat Technologies - Ratings and Ratios
Geothermal, Solar, Recovered-Energy, Battery-Storage
Dividends
| Dividend Yield | 0.42% |
| Yield on Cost 5y | 0.65% |
| Yield CAGR 5y | 2.20% |
| Payout Consistency | 91.7% |
| Payout Ratio | 21.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.1% |
| Value at Risk 5%th | 42.0% |
| Relative Tail Risk | -2.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 34.07 |
| CAGR/Max DD | 0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.454 |
| Beta | 0.521 |
| Beta Downside | 0.571 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.68% |
| Mean DD | 16.57% |
| Median DD | 18.43% |
Description: ORA Ormat Technologies November 06, 2025
Ormat Technologies Inc. (NYSE:ORA) develops, builds, owns, and operates geothermal, solar PV, and recovered-energy power plants, while also manufacturing equipment and providing EPC services for these assets. The business is organized into three segments: Electricity (power generation and sales), Product (equipment design and sales), and Energy Storage (battery systems and related services). Its customer base spans contractors, plant owners, and operators across a range of energy-intensive industries worldwide.
Key quantitative points to note: • In FY 2023 Ormat reported adjusted EBITDA of approximately **$320 million**, reflecting a 12 % YoY increase driven by higher plant output and new project commissions. • The company’s development pipeline includes **~2 GW** of geothermal capacity slated for construction by 2027, primarily in the United States, Indonesia, and Kenya. • Geothermal generation benefits from long-term power purchase agreements (PPAs) and federal tax incentives such as the Investment Tax Credit (ITC), which together underpin a relatively stable cash-flow profile even amid volatile electricity markets. Sector-wide, global geothermal capacity is expected to grow at **~5 % CAGR** through 2030, supported by decarbonization mandates and the need for firm, low-carbon baseload power.
For a deeper dive into ORA’s valuation metrics and peer comparisons, the ValueRay platform offers a concise, data-rich overview worth checking out.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (133.4m TTM) > 0 and > 6% of Revenue (6% = 56.7m TTM) |
| FCFTA -0.09 (>2.0%) and ΔFCFTA -6.41pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -15.90% (prev -3.24%; Δ -12.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 388.7m > Net Income 133.4m (YES >=105%, WARN >=100%) |
| Net Debt (2.68b) to EBITDA (544.7m) ratio: 4.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (61.1m) change vs 12m ago 0.60% (target <= -2.0% for YES) |
| Gross Margin 28.32% (prev 31.17%; Δ -2.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 16.16% (prev 15.92%; Δ 0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.85 (EBITDA TTM 544.7m / Interest Expense TTM 141.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.88
| (A) -0.02 = (Total Current Assets 504.7m - Total Current Liabilities 654.8m) / Total Assets 6.09b |
| (B) 0.15 = Retained Earnings (Balance) 885.2m / Total Assets 6.09b |
| (C) 0.04 = EBIT TTM 261.6m / Avg Total Assets 5.84b |
| (D) 0.26 = Book Value of Equity 878.0m / Total Liabilities 3.44b |
| Total Rating: 0.88 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.97
| 1. Piotroski 3.0pt |
| 2. FCF Yield -5.74% |
| 3. FCF Margin -57.31% |
| 4. Debt/Equity 1.10 |
| 5. Debt/Ebitda 4.91 |
| 6. ROIC - WACC (= -1.56)% |
| 7. RoE 5.39% |
| 8. Rev. Trend 85.89% |
| 9. EPS Trend 39.48% |
What is the price of ORA shares?
Over the past week, the price has changed by +0.63%, over one month by +1.94%, over three months by +24.08% and over the past year by +53.64%.
Is ORA a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ORA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.6 | 3.7% |
| Analysts Target Price | 117.6 | 3.7% |
| ValueRay Target Price | 126.1 | 11.3% |
ORA Fundamental Data Overview December 02, 2025
P/E Trailing = 50.9862
P/E Forward = 49.2611
P/S = 7.1548
P/B = 2.7344
P/EG = 4.9263
Beta = 0.743
Revenue TTM = 944.2m USD
EBIT TTM = 261.6m USD
EBITDA TTM = 544.7m USD
Long Term Debt = 2.29b USD (from longTermDebt, last quarter)
Short Term Debt = 432.1m USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.68b USD (from netDebt column, last quarter)
Enterprise Value = 9.43b USD (6.76b + Debt 2.75b - CCE 79.6m)
Interest Coverage Ratio = 1.85 (Ebit TTM 261.6m / Interest Expense TTM 141.4m)
FCF Yield = -5.74% (FCF TTM -541.2m / Enterprise Value 9.43b)
FCF Margin = -57.31% (FCF TTM -541.2m / Revenue TTM 944.2m)
Net Margin = 14.12% (Net Income TTM 133.4m / Revenue TTM 944.2m)
Gross Margin = 28.32% ((Revenue TTM 944.2m - Cost of Revenue TTM 676.8m) / Revenue TTM)
Gross Margin QoQ = 25.64% (prev 24.31%)
Tobins Q-Ratio = 1.55 (Enterprise Value 9.43b / Total Assets 6.09b)
Interest Expense / Debt = 1.30% (Interest Expense 35.7m / Debt 2.75b)
Taxrate = 14.77% (4.28m / 29.0m)
NOPAT = 223.0m (EBIT 261.6m * (1 - 14.77%))
Current Ratio = 0.77 (Total Current Assets 504.7m / Total Current Liabilities 654.8m)
Debt / Equity = 1.10 (Debt 2.75b / totalStockholderEquity, last quarter 2.51b)
Debt / EBITDA = 4.91 (Net Debt 2.68b / EBITDA 544.7m)
Debt / FCF = -4.94 (negative FCF - burning cash) (Net Debt 2.68b / FCF TTM -541.2m)
Total Stockholder Equity = 2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 133.4m / Total Assets 6.09b)
RoE = 5.39% (Net Income TTM 133.4m / Total Stockholder Equity 2.47b)
RoCE = 5.49% (EBIT 261.6m / Capital Employed (Equity 2.47b + L.T.Debt 2.29b))
RoIC = 4.40% (NOPAT 223.0m / Invested Capital 5.07b)
WACC = 5.96% (E(6.76b)/V(9.51b) * Re(7.94%) + D(2.75b)/V(9.51b) * Rd(1.30%) * (1-Tc(0.15)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.52%
Fair Price DCF = unknown (Cash Flow -541.2m)
EPS Correlation: 39.48 | EPS CAGR: 0.0% | SUE: 0.26 | # QB: 0
Revenue Correlation: 85.89 | Revenue CAGR: 7.41% | SUE: 2.71 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.89 | Chg30d=+0.202 | Revisions Net=+6 | Analysts=7
EPS next Year (2026-12-31): EPS=2.55 | Chg30d=+0.091 | Revisions Net=+2 | Growth EPS=+17.1% | Growth Revenue=+16.5%
Additional Sources for ORA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle